Just drive it down, jump back in, and start cheerleading again. Everyone knows your game. Ultimately, it doesn't matter what any of us thinks about any of these numbers. If the results (once the study is actually finished) convince a big pharma to enter a JV, that will trump all of this. Let's wait until the final numbers are presented before declaring Lympro a failure. I still believe today's data was positive, but just misunderstood by everyone. Why would they bother presenting it otherwise? Why would the rest of the study even continue otherwise? Why would the company express its excitement about the data otherwise? Final data will tell all. Read Fibonacci's tweets from tonight...p-value is very important. Before you criticize Fibonacci, go re-read some of your own tweets from the last few weeks.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links